Literature DB >> 23970352

Transplants for the elderly in myeloma.

Gareth J Morgan1.   

Abstract

In this issue of Blood, Gay et al provide important new information that can be used to design future phase 3 trials.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23970352     DOI： 10.1182/blood-2013-07-510941

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


  4 in total

1.  Autotransplants in older multiple myeloma patients: hype or hope in the era of novel agents?

Authors:  Monika Engelhardt; Gabriele Ihorst; Jo Caers; Andreas Günther; Ralph Wäsch
Journal:  Haematologica       Date:  2016-11       Impact factor: 9.941

2.  Approach to the Older Adult With Multiple Myeloma.

Authors:  Roberto Mina; Sara Bringhen; Tanya M Wildes; Sonja Zweegman; Ashley E Rosko
Journal:  Am Soc Clin Oncol Educ Book       Date:  2019-05-17

3.  European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma.

Authors:  Monika Engelhardt; Evangelos Terpos; Martina Kleber; Francesca Gay; Ralph Wäsch; Gareth Morgan; Michele Cavo; Niels van de Donk; Andreas Beilhack; Benedetto Bruno; Hans Erik Johnsen; Roman Hajek; Christoph Driessen; Heinz Ludwig; Meral Beksac; Mario Boccadoro; Christian Straka; Sara Brighen; Martin Gramatzki; Alessandra Larocca; Henk Lokhorst; Valeria Magarotto; Fortunato Morabito; Meletios A Dimopoulos; Hermann Einsele; Pieter Sonneveld; Antonio Palumbo
Journal:  Haematologica       Date:  2014-02       Impact factor: 9.941

4.  Racial disparity in utilization of therapeutic modalities among multiple myeloma patients: a SEER-medicare analysis.

Authors:  Sikander Ailawadhi; Ryan D Frank; Pooja Advani; Abhisek Swaika; M'hamed Temkit; Richa Menghani; Mayank Sharma; Zahara Meghji; Shumail Paulus; Nandita Khera; Shahrukh K Hashmi; Aneel Paulus; Tanya S Kakar; David O Hodge; Dorin T Colibaseanu; Michael R Vizzini; Vivek Roy; Gerardo Colon-Otero; Asher A Chanan-Khan
Journal:  Cancer Med       Date:  2017-11-03       Impact factor: 4.452
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.